Skip to content

Intelligent Diagnosis of Strabismus Based on High-Speed Eye Tracking Technology

Intelligent Diagnosis of Strabismus Based on High-Speed Eye Tracking Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117187
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-01-25
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus

Interventions

Group A:None
Group B:None
Group C:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnostic Criteria: Patients must be diagnosed by a professional ophthalmologist with either intermittent exotropia or constant exotropia, supported by detailed measurements of the deviation angle and results from ocular examinations . 2.Age Range: Participants enrolled in the study should be between 10 and 70 years of age. 3.Gender: There are no restrictions based on gender; both male and female patients are eligible to participate. 4.Visual Acuity: The best-corrected visual acuity (BCVA) in the worse-seeing eye must be <= 0.00 logMAR. 5.Spherical Equivalent Refraction: The spherical equivalent must fall within the range of +4.00 D to -10.00 D. 6.Compliance: Participants must be willing and able to cooperate with wearing the eye-tracker to complete the examination. 7.Exclusion Criteria: Absence of any ocular diseases, systemic diseases, mental illnesses, or developmental disorders.

Exclusion criteria

Exclusion criteria: 1.Patients diagnosed with strabismus other than intermittent exotropia or constant exotropia, including esotropia, A-V pattern strabismus, dissociated vertical deviation, restrictive strabismus, paralytic strabismus, and nystagmus. 2.Patients with other ocular diseases besides strabismus, such as glaucoma, cataract, amblyopia, or ocular trauma. 3.Patients with congenital cranial dysinnervation disorders or systemic neurological developmental abnormalities. 4.Patients with systemic diseases, such as hypertension, diabetes, thyroid disorders, or heart disease. 5.Patients with developmental disorders or mental health conditions. 6.Patients who did not provide written informed consent or demonstrated poor cooperation leading to an inability to maintain fixation.

Design outcomes

Primary

MeasureTime frame
Eye Movement Metrics;Prismatic Deviation of Strabismus;

Secondary

MeasureTime frame
Strabismus Angle Measured by Synoptophore;

Countries

China

Contacts

Public ContactZhiyue Dai

Eye Hospital, Wenzhou Medical University

dzy@eye.ac.cn+86 577 88068816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026